News about Global Pharma

Formation Bio Bags USD 372 MM in Series D Funding

Formation Bio has raised USD 372 MM of Series D financing.

Global Pharma | 28/06/2024 | By Aishwarya |  624

CASI Pharmaceuticals Plans to Submit IND Application For CID-103

CASI Pharmaceuticals, Inc. has planned to submit an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for CID-103 for the treatment of antibody-mediated rejection (AMR) in kidney transplant recipients by the end of 2024.

Global Pharma | 28/06/2024 | By Aishwarya |  669

Cellares Signs Deal with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform

Cellares has announced that Kite will evaluate Cellares’ automated manufacturing platform, the Cell Shuttle.

Global Pharma | 28/06/2024 | By Aishwarya |  540

Glenmark and IADVL Raise Awareness Campaign to Support Vitiligo Patients in India

Glenmark Pharmaceuticals Ltd. has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL), to unveil postcards & Calendars aimed at raising awareness.

Global Pharma | 28/06/2024 | By Aishwarya |  757

Verona Pharma Secures US FDA Approval of Ohtuvayre

Verona Pharma has announced that the US Food and Drug Administration (FDA) approved Ohtuvayre (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.

Global Pharma | 27/06/2024 | By Aishwarya |  1060

Cipla and Takeda to Commercialize Vonoprazan in India

Cipla has signed a non-exclusive Patent License agreement with Takeda Pharmaceutical company Ltd. for ‘Vonoprazan’ for India Market for treating acid-related illnesses among patients.

Global Pharma | 27/06/2024 | By Aishwarya |  1208

Skyhawk Therapeutics Inaugurates its State-of-the-Art Labs in Switzerland

Skyhawk Therapeutics, Inc. has expanded its facilities with its new state-of-the-art labs in Superlab Suisse, in Basel Switzerland.

Global Pharma | 26/06/2024 | By Aishwarya |  1008

Sen-Jam Pharma Completes Enrollment for Phase 2 URIs or COVID

Sen-Jam Pharmaceutical has completed participant enrollment for the clinical trial of its innovative therapeutic, SJP-002C in partnership with Duke University.

Global Pharma | 25/06/2024 | By Aishwarya |  699

Cypris Therapeutics Bags Over USD 500k in Pre-Seed Funding

Cypris Therapeutics has introduced a breakthrough in synthetic chemistry technology which allows development of novel chemistries for treatment of therapeutically resistant diseases, including brain and pancreatic cancers.

Global Pharma | 25/06/2024 | By Aishwarya |  812

ANI Pharmaceuticals to Acquire Alimera to Expand Rare Disease

ANI Pharmaceuticals, Inc. has announced that ANI will acquire Alimera for USD 5.50 per share in cash at closing and one non-tradable contingent value right (CVR) representing the right to receive up to USD 0.50 per share upon the achievement of certain net revenue targets in 2026 and 2027.

Global Pharma | 25/06/2024 | By Aishwarya |  777